PRVL
Nuveen Asset Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-87,660
| Closed | -$1.1M | – | 3335 |
|
|
2020
Q4 | $1.1M | Sell |
87,660
-13,686
| -14% | -$171K | ﹤0.01% | 2771 |
|
|
2020
Q3 | $1.03M | Buy |
101,346
+37,727
| +59% | +$384K | ﹤0.01% | 2673 |
|
|
2020
Q2 | $948K | Buy |
63,619
+13,889
| +28% | +$207K | ﹤0.01% | 2639 |
|
|
2020
Q1 | $606K | Buy |
49,730
+31,899
| +179% | +$389K | ﹤0.01% | 2703 |
|
|
2019
Q4 | $282K | Sell |
17,831
-6,576
| -27% | -$104K | ﹤0.01% | 3025 |
|
|
2019
Q3 | $299K | Buy |
+24,407
| New | +$299K | ﹤0.01% | 3050 |
|